Background: Little is known about the relative impact of the preoperative symptoms rest pain and tissue loss, and of the arterial segment revascularized, on amputation rate and mortality in patients with chronic limb-threatening ischemia (CLTI). We wanted to investigate this topic further. Method: This population-based observational cohort study involved 10 419 patients revascularized for CLTI in Sweden, 2008 to 2013. Data were collected from health-care registries and medical records. The effect of preoperative symptoms and revascularized arteries was determined using Cox regression models. A competing risk analysis was used to determine the effect of symptoms on the combined endpoint "amputation or death". Results: The amputation rate during a mean follow-up of 2 years was 7.5% in patients with rest pain, 15.6% in patients with tissue loss only, and 20.1% when both symptoms were present. Mortality was 39% lower in patients with rest pain only than in those with both symptoms. Revascularizations targeted the aortoiliac, femoropopliteal, and infrapopliteal segments in 19.4%, 76.8%, and 30.6%, respectively. Distal revascularizations were associated with a higher amputation rate, but this difference disappeared after adjustment for comorbidities. Aortoiliac revascularizations were associated with high mortality. Competing risk analysis showed that mortality became the major determinant of amputation-free survival outcomes from 1 year after revascularization. Conclusions: Tissue loss implies a clearly worse prognosis compared to rest pain for patients with CLTI. Most revascularizations for CLTI are done in the femoropopliteal segment. Infrapopliteal procedures are associated with a higher amputation rate, whereas aortoiliac revascularizations are associated with higher mortality.
Introduction
The burden of peripheral arterial disease (PAD) is increasing worldwide. 1 Its most severe manifestation, chronic limbthreatening ischemia (CLTI), is defined as rest pain and/or tissue loss (ulceration/gangrene) in the lower extremity caused by ischemia. Guidelines recommend invasive revascularization in patients with CLTI to increase tissue perfusion and decrease the amputation risk when anatomically and technically feasible. 2 However, recommendations for revascularization do not differentiate between patients who present with rest pain, tissue loss, or a combination of the 2. Consequently, in clinical practice, the decision threshold to revascularize is reached when a patient has at least 1 of these symptoms. In the literature, there is little information on the relative effect of each preoperative symptom on outcomes after surgical treatment for CLTI.
Lower-limb PAD involves occlusive lesions in the aortoiliac arterial segment, the femoropopliteal segment, and the infrapopliteal segment. Solitary lesions in the aortoiliac or femoropopliteal arteries usually cause intermittent claudication (IC), while lesions confined to infrapopliteal arteries are associated with diabetes mellitus and CLTI. This is reflected in the European Society of Cardiology/European Society for Vascular Surgery guidelines, 2 in which invasive treatment of aortoiliac and femoropopliteal lesions is described only for IC, and invasive treatment of infrapopliteal lesions is described for patients with CLTI. However, patients with PAD often have multilevel disease, with obstructing lesions in several vascular segments. Multilevel disease may cause both IC and CLTI, depending on the combined flow-reducing effect, and many patients with CLTI are treated invasively for lesions proximal to the infrapopliteal arteries.
In this study, we hypothesized that presenting symptoms affect the risk of amputation and death and that the majority of invasive procedures for CLTI target lesions proximal to the infrapopliteal arteries.
Methods
This nationwide observational cohort study was based on prospectively collected data from mandatory national health-care registries. In order to ensure that the data were accurate, the data set was complemented by reviewing medical records.
Patients
The cohort of 10 419 patients, consisting of all patients older than 50 years who were revascularized for CLTI in Sweden between May 12, 2008 , and May 1, 2013, was identified in the Swedvasc register. 3, 4 This register contains information on all peripheral arterial procedures in Sweden, and its data accuracy has repeatedly been validated. 5, 6 Individual patient informed consent is not required for register studies in Sweden. Patients were included if they had undergone an open surgical or endovascular arterial revascularization between the infrarenal aorta and an infrapopliteal artery and are presented with preoperative symptoms of rest pain or tissue loss or both, that is, Rutherford classification stage. [4] [5] [6] 7 The age limit was set to avoid inclusion of patients treated for nonatherosclerotic vascular disease.
Preoperative Symptoms
Preoperative symptoms were collected from the Swedvasc register. In the register, symptoms of CLTI are recorded dichotomously (yes or no) as 2 separate variables: the presence of rest pain and the presence of tissue loss (ischemic wounds or gangrene). In the analysis, the revascularized patients with CLTI were divided into 3 groups based on preoperative symptoms: rest pain only, tissue loss only, and a combination of both.
Arterial Segment Revascularized
The arterial segment revascularized was identified from the Swedvasc register. In the register, the revascularized segments are registered according to the preoperative inflow and outflow artery. The lower-limb arteries were divided into 3 anatomical segments: the aortoiliac, the femoropopliteal, and the infrapopliteal. Revascularizations targeted 1 or several of these segments.
Amputations
Data on amputations were collected from the National Inpatient Register (NPR) for dates up to December 31, 2013. All Swedish health-care providers report surgical procedures to the NPR. Coverage is >99% and the data are well validated. 8 The NPR uses the International Classification of Diseases, 10th revision (ICD-10), for coding. Amputations were defined as hip exarticulation (NFQ09), transfemoral amputation (NFQ19), knee exarticulation (NGQ09), or transtibial amputation (NGQ19). Minor amputations (toe, metatarsal, or forefoot) were not included in the analysis. In the data managing process, any uncertainty (including laterality and amputation level) regarding a specific amputation event was sorted out by reviewing the patient's medical charts at the treating hospital. Altogether, the medical records of 1366 patients were reviewed.
Deaths
Dates of deaths were collected from the national Cause of Death Register for dates up to May 13, 2015 . The Cause of Death Register contains the dates of all deaths of Swedish citizens, occurring in Sweden and abroad. The high accuracy of the register has been confirmed in validation studies. 9 
Comorbidities
Information on comorbidities was not initially included in the merged database. It was amended during the analysis phase of the study to investigate whether associations between symptoms, arterial segments, and the outcome variables were dependent or independent of preoperative comorbidities. For this purpose, information on preoperative comorbidities was retrieved from the NPR; it could be retrieved for 9828 (94%) of the patients. Which comorbidities to include in the analysis were based on results from our previous work in a similar cohort. 10 
Ethics
The study was approved by the Regional Ethical Review Board of the University of Gothenburg (reference number 873-14 and T084-16).
Statistics
Baseline characteristics are presented as absolute numbers, and relative frequencies stratified according to baseline symptoms and also according to the arterial segment revascularized. Cox proportional hazards model was used to analyze the risk of amputation, death, and the combination of both (ie, 3 separate models), in which age, gender, comorbidities, lower-limb CLTI symptoms, and revascularization level were introduced a priori in the model as potential risk factors. Time from revascularization was used as the primary timescale in the models.
The results are presented as hazard ratios and Kaplan-Meier curves. In addition, a competing risk model was created to study the risk of major amputation while taking into account death as a competing risk. The statistical analysis was done using SAS version 9.3 (SAS Institute, Inc, Cary, North Carolina) and R version 3.5.0 (The R Foundation for Statistical Computing, Vienna, Austria).
Results
Demographics, symptoms, and arterial segments of revascularization procedures are presented in Tables 1 to 3 . The proportion of endovascular versus open revascularizations was 74.3% versus 22.6% and 3.1% was hybrid procedures. Most patients had a combination of rest pain and tissue loss (53.9%). Among patients with tissue loss, the prevalence of diabetes was higher.
Diabetes was present in 30.4% of patients with rest pain only, in 55.2% of patients with tissue loss only, and in 48.6% of patients with both rest pain and tissue loss. The prevalence of heart failure was 50% higher in patients with both rest pain and tissue loss compared to those with pain only. Most of the CLTI revascularizations (76.8%) included the femoropopliteal arterial segment. Fifty percent of procedures were done in the femoropopliteal segment only, and another 3.3% and 23.5% also included inflow and outflow procedures in the aortoiliac and the infrapopliteal segments, respectively. Infrapopliteal lesions were involved in the treatment in less than one-third of patients with CLTI (30.6%), of which 7.1% were isolated treated infrapopliteal. Approximately one-fifth of patients with CLTI (19.4%) were revascularized in the aortoiliac segment. Isolated femoropopliteal revascularizations were common in patients with rest pain only (54.3%), while revascularizations including the infrapopliteal segment were relatively more frequent in patients with tissue loss only (29.4%).
Major Amputation
The mean follow-up time for amputations was 2.0 years (range 0-5.6). Associations between preoperative symptoms, arterial segment revascularized, and amputation are presented in Table 4 .
Preoperative Symptoms
Patients with tissue loss had twice the rate of amputations (15.6%) than patients with rest pain only (7.5%) during follow-up. The amputation rate in patients with both symptoms was 20.1%. Differences between the 3 groups were mainly seen during the first 6 months. After that, amputations decreased to similar, lower rates in all groups (Figure 1) . Most of the amputations in all groups were transtibial. Kaplan-Meier estimates on time to amputation, stratified according to presenting symptoms, are presented in Figure 1 . In the multivariable analysis, hazard ratios (HRs) for ipsilateral amputation in patients with rest pain only and tissue loss only were 0.37 (95% CI, 0.31-0.43; P < .001) and 0.72 (95% CI, 0.64-0.82; P < .001), respectively, compared to patients with both symptoms (Table 5) . 
Arterial Segment Revascularized
Distal revascularizations had higher amputation rates than proximal revascularizations; 24.3% of patients with an isolated infrapopliteal revascularization had an amputation during follow-up, as compared to 16.6% with isolated femoropopliteal revascularization and 14.0% with isolated aortoiliacal revascularization. However, in the multivariable-adjusted model including preoperative comorbidities, which is presented in Table 5 , there was no significant difference in the relative risk of amputation based on revascularization level (HR for infrapopliteal vs aortoiliacal 1.04, 95% CI, 0.84-1.28; P ¼ .720).
Amputation Level
The amputation level was found to correlate with the arterial segment revascularized; transfemoral amputations were more common after proximal reconstructions, and transtibial amputations were more common after femoropopliteal and infrapopliteal revascularizations (Table 4) .
Mortality
Mean follow-up time for mortality was 3.0 years (range 0-7). The cumulative incidence of death, stratified according to presenting symptoms, is shown in Figure 2 , and the cumulative incidence of either amputation or death is shown in Figure 3 .
Preoperative Symptoms
In the multivariable-adjusted model, presented in Table 5 , patients with rest pain alone had 41% lower mortality risk than patients with both rest pain and tissue loss (HR 0.59, 95% CI, 0.54-0.63; P < .001).
Anatomic Level of Revascularization
Revascularization of the femoropopliteal segment and the infrapopliteal segment was associated with lower mortality than revascularization of the aortoiliac segment. Compared to aortoiliac procedures, femoropopliteal revascularization gave an HR for mortality of 0.73 (95% CI, 0.67-0.79; P < .001) while infrapopliteal revascularization gave an HR of 0.70 (95% CI, 0.62-0.80; P < .001; Table 5 ).
Competing Risk Analysis for Death and Amputation
In order to determine how mortality in patients with CLTI affected the estimation of amputation risk over time, a competing risk analysis was performed ( Figure 4 ). The curves of the Kaplan-Meier risk estimate followed the competing risk estimate during the first 6 months; thereafter, the difference between the curves increased, indicating an increasing risk of death compared to the risk of amputation. This effect was most pronounced in patients with ischemic tissue loss.
Discussion
The main findings in this study of all patients who were revascularized for CLTI in Sweden during a 5-year period were as follows: (1) The risk of lower-limb amputation is doubled when presenting symptoms include ischemic tissue loss rather than rest pain alone. (2) The majority of lowerlimb revascularizations for CLTI are performed in the femoropopliteal arterial segment, not in the infrapopliteal vessels. (3) The more distal the revascularization performed, the higher the amputation rate, due to differences in preoperative comorbidities. (4) Mortality is higher for the most proximal revascularizations in the aortoiliac segment.
In the literature and in clinical practice, CLTI is often seen as being one entity. At the same time, it is already known that ischemic wounds or gangrene increase the risk of amputation. 11, 12 This is reflected in the WIfI risk stratification, based on assessment of wound, ischemia, and foot infection (WIfI). 13 Our results support the WIfI recommendations and contribute by quantifying the specific amputation risk after revascularization based on the presence or absence of rest pain and tissue loss. We found that preoperative tissue loss is a markedly worse prognostic factor for amputation than rest pain. For patients with tissue loss, the presence of rest pain increases the risk of amputation even further. Patients with rest pain only had approximately one-third of the amputation rate compared to those with both rest pain and tissue loss. Diabetic neuropathy may explain why some patients with tissue loss had no rest pain. Presence of neuropathy was not recorded in our data. This is a limitation. However, for practical reasons, symptoms of patients with CLTI are commonly described by affirming or negating rest pain and/or tissue loss, while the diagnosis of neuropathy is somewhat more elusive and less often used in treatment recommendations and guidelines. Other studies have failed to demonstrate associations between the risk of amputation and the presence of diabetic neuropathy. 14 We have previously shown that the overall amputation risk is particularly high during the first 6 months after a revascularization procedure. 15 In this study, we found that most of the early amputations, during the first 6 months were done in patients with preoperative tissue loss. Beyond 6 months, amputation risk was markedly lower irrespective of presenting symptoms. Competing risk analysis for amputation and death showed that while the risk of amputation stabilized at a lower level after 1 year, the risk of death increasingly affected the overall results (ie, amputation), which is in accordance with recently published work. 16 An interesting finding was that the majority of the revascularization procedures, regardless of CLTI symptomatology, were performed in the femoropopliteal segment and not in the infrapopliteal arteries. This contrasts with current European guidelines, where recommendations on revascularization for CLTI focus only on the infrapopliteal arteries.
2 Our interpretation is that although infrapopliteal lesions are present in the vast majority of patients with CLTI, multisegment disease is common and feasible revascularization options are usually found in more proximal vessels.
In the one-third of patients with a revascularization involving the infrapopliteal segment, the rate of amputation was higher than in patients with more proximal procedures. This difference disappeared after adjustment for comorbidities including diabetes, chronic renal insufficiency, and heart failure. In crude numbers, most amputations occurred after isolated femoropopliteal revascularizations. The amputation level correlated with the arterial segment revascularized; proximal amputations were more common after proximal reconstructions.
To the best of our knowledge, no previous study has found a correlation between the arterial segment of revascularization for CLTI and postoperative mortality. We found that proximal revascularization, in the aortoiliac artery segment, was associated with the highest mortality. This might be an effect of more widespread atherosclerotic disease in patients with CLTI undergoing a proximal procedure. The specific causes of death in this subgroup of patients would be interesting to investigate further in future studies.
The main strength of the present study was the large and complete cohort, made possible by well-validated mandatory national registries. The main weakness is that registry data are inherently subject to judgment bias, and possibly mistakes, by caregivers. To minimize inaccuracies in the principal outcome, lower-limb amputation, we complemented registry data by reviewing a large number of medical records. In addition, the inclusion of preoperative comorbidities for the multivariate analysis was not initially planned, and we were not able to acquire full comorbidity data on 6% of the patients.
Conclusion
The CLTI is far from being a singular clinical entity in terms of disease severity and prognosis. Patients with CLTI who present with both rest pain and tissue loss have a 3-fold higher risk of amputation and a doubled mortality risk compared to those who present with rest pain alone. Most revascularizations for CLTI are done in the femoropopliteal arterial segment. Distal revascularizations have a higher amputation rate, which can be explained by differences in preoperative comorbidities. Proximal revascularizations in the aortoiliac arteries are associated with higher mortality.
